These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 35311097)

  • 1. NcRNA-Mediated High Expression of
    Jiang X; Tang L; Yuan Y; Wang J; Zhang D; Qian K; Cho WC; Duan L
    Front Oncol; 2022; 12():846536. PubMed ID: 35311097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Non-Coding RNA-TMPO-AS1 as ceRNA Binding to let-7c-5p Upregulates STRIP2 Expression and Predicts Poor Prognosis in Lung Adenocarcinoma.
    Wang J; Yuan Y; Tang L; Zhai H; Zhang D; Duan L; Jiang X; Li C
    Front Oncol; 2022; 12():921200. PubMed ID: 35774125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-promoting roles of HMMR in lung adenocarcinoma.
    Wang Q; Wu G; Fu L; Li Z; Wu Y; Zhu T; Yu G
    Mutat Res; 2023; 826():111811. PubMed ID: 36603370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma.
    Ma X; Xie M; Xue Z; Yao J; Wang Y; Xue X; Wang J
    Comput Biol Med; 2022 Dec; 151(Pt A):106213. PubMed ID: 36306573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC00665 promotes glycolysis in lung adenocarcinoma cells via the let-7c-5p/HMMR axis.
    Li Z; Zhu T; Yao F; Shen X; Xu M; Fu L; Wu Y; Ding J; Zhang J; Zhao J; Dong L; Wang X; Yu G
    J Bioenerg Biomembr; 2024 Apr; 56(2):181-191. PubMed ID: 38411863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCG18/miR-34a-5p/HMMR axis accelerates the progression of lung adenocarcinoma.
    Li W; Pan T; Jiang W; Zhao H
    Biomed Pharmacother; 2020 Sep; 129():110217. PubMed ID: 32559619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
    Mu X; Wu H; Liu J; Hu X; Wu H; Chen L; Liu W; Luo S; Zhao Y
    Biomed Pharmacother; 2020 May; 125():109989. PubMed ID: 32062549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma.
    Wang N; Zhu L; Xu X; Yu C; Huang X
    Comput Struct Biotechnol J; 2022; 20():4390-4401. PubMed ID: 36051873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA HMMR-AS1 promotes proliferation and metastasis of lung adenocarcinoma by regulating MiR-138/sirt6 axis.
    Cai Y; Sheng Z; Chen Y; Wang J
    Aging (Albany NY); 2019 May; 11(10):3041-3054. PubMed ID: 31128573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating
    Li X; Zuo H; Zhang L; Sun Q; Xin Y; Zhang L
    Front Oncol; 2021; 11():720302. PubMed ID: 34527588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.
    Liu T; Yang C; Wang W; Liu C
    Thorac Cancer; 2021 Jul; 12(14):2104-2112. PubMed ID: 34061466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
    Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
    Front Immunol; 2021; 12():724741. PubMed ID: 34335635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Lung Adenocarcinoma by Comprehensive Bioinformatics Analysis and
    Li X; Chen X; Yuan Y; Zhai R; Cho WC; Jiang X
    Front Oncol; 2022; 12():916947. PubMed ID: 35707363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-Related miRNA-195-5p Inhibits the Progression of Lung Adenocarcinoma by Targeting Polypyrimidine Tract-Binding Protein 1.
    Duan L; Wang J; Zhang D; Yuan Y; Tang L; Zhou Y; Jiang X
    Front Oncol; 2022; 12():862564. PubMed ID: 35600383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA CERS6-AS1 upregulates the expression of ANLN by sponging miR-424-5p to promote the progression and drug resistance of lung adenocarcinoma.
    Ting Z; Wu Z; Yang C; Li Z; Huang H; Gan J; Li N; Li X; Lyu J; Wu Y; Qin S
    Noncoding RNA Res; 2024 Mar; 9(1):221-235. PubMed ID: 38094657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
    Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L
    Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TMPO-AS1, a Novel E2F1-Regulated lncRNA, Contributes to the Proliferation of Lung Adenocarcinoma Cells via Modulating miR-326/SOX12 Axis.
    Wei L; Liu Y; Zhang H; Ma Y; Lu Z; Gu Z; Ding C
    Cancer Manag Res; 2020; 12():12403-12414. PubMed ID: 33293866
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Wu C; Dong B; Huang L; Liu Y; Ye G; Li S; Qi Y
    Front Oncol; 2021; 11():754290. PubMed ID: 34745988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased zinc-fingers and homeoboxes family expression was associated with unfavorable outcomes and immune infiltration in lung adenocarcinoma.
    Tao D; Tan J; Zhang N; Yang D; Jiang Y; Zhou W; Wang Y; Wu Y
    Transl Cancer Res; 2023 Jun; 12(6):1422-1440. PubMed ID: 37434685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.